Adenoid Cystic Carcinoma of the Breast May Be Exempt from Adjuvant Chemotherapy

Consistent standards regarding whether postoperative adjuvant chemotherapy is required in the treatment of adenoid cystic carcinoma of the breast (ACCB) are currently lacking. Using clinical data from the Surveillance, Epidemiology, and End Results (SEER) database (1988–2015), and the National Cance...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Lixi, Zhang, Di, Ma, Fei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9369505/
https://www.ncbi.nlm.nih.gov/pubmed/35956093
http://dx.doi.org/10.3390/jcm11154477

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9369505/
https://www.ncbi.nlm.nih.gov/pubmed/35956093
http://dx.doi.org/10.3390/jcm11154477

Ejemplares similares